Dextrothyroxine
（重定向自Dextrothyroxine sodium）
![](/Images/godic/202501/08/Dextrothyroxine_skeletal.svg4049.png")
Dextrothyroxine (trade name Choloxin) saw research as a cholesterol-lowering drug but was pulled due to cardiac side-effects. It also increases hepatic lipase which in turn improves utilization of triglycerides, improving apolipoprotein E cholesterol particles.